<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38317683</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>Prevalence, predictors, and patient-reported outcomes of long COVID in hospitalized and non-hospitalized patients from the city of S&#xe3;o Paulo, Brazil.</ArticleTitle><Pagination><StartPage>1302669</StartPage><MedlinePgn>1302669</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1302669</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2023.1302669</ELocationID><Abstract><AbstractText Label="BACKGROUND">Robust data comparing long COVID in hospitalized and non-hospitalized patients in middle-income countries are limited.</AbstractText><AbstractText Label="METHODS">A retrospective cohort study was conducted in Brazil, including hospitalized and non-hospitalized patients. Long COVID was diagnosed at 90-day follow-up using WHO criteria. Demographic and clinical information, including the depression screening scale (PHQ-2) at day 30, was compared between the groups. If the PHQ-2 score is 3 or greater, major depressive disorder is likely. Logistic regression analysis identified predictors and protective factors for long COVID.</AbstractText><AbstractText Label="RESULTS">A total of 291 hospitalized and 1,118 non-hospitalized patients with COVID-19 were included. The prevalence of long COVID was 47.1% and 49.5%, respectively. Multivariable logistic regression showed female sex (odds ratio [OR]&#x2009;=&#x2009;4.50, 95% confidence interval (CI) 2.51-8.37), hypertension (OR&#x2009;=&#x2009;2.90, 95% CI 1.52-5.69), PHQ-2&#x2009;&gt;&#x2009;3 (OR&#x2009;=&#x2009;6.50, 95% CI 1.68-33.4) and corticosteroid use during hospital stay (OR&#x2009;=&#x2009;2.43, 95% CI 1.20-5.04) as predictors of long COVID in hospitalized patients, while female sex (OR&#x2009;=&#x2009;2.52, 95% CI 1.95-3.27) and PHQ-2&#x2009;&gt;&#x2009;3 (OR&#x2009;=&#x2009;3.88, 95% CI 2.52-6.16) were predictors in non-hospitalized patients.</AbstractText><AbstractText Label="CONCLUSION">Long COVID was prevalent in both groups. Positive depression screening at day 30 post-infection can predict long COVID. Early screening of depression helps health staff to identify patients at a higher risk of long COVID, allowing an early diagnosis of the condition.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Malheiro, Bernardez-Pereira, Parreira, Pagliuso, de Paula Gomes, de Mesquita Escobosa, de Ara&#xfa;jo, Pimenta, Lin, de Almeida, Tuma, Laselva, Neto, Klajner, Teich, Kobayashi, Edmond and Marra.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Malheiro</LastName><ForeName>Daniel Tavares</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernardez-Pereira</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parreira</LastName><ForeName>Kau&#xea; Capellato Junqueira</ForeName><Initials>KCJ</Initials><AffiliationInfo><Affiliation>Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pagliuso</LastName><ForeName>Jo&#xe3;o Gabriel Dias</ForeName><Initials>JGD</Initials><AffiliationInfo><Affiliation>Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Paula Gomes</LastName><ForeName>Emerson</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Mesquita Escobosa</LastName><ForeName>Daisa</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Ara&#xfa;jo</LastName><ForeName>Carolina Ivo</ForeName><Initials>CI</Initials><AffiliationInfo><Affiliation>Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pimenta</LastName><ForeName>Beatriz Silva</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Vivian</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Almeida</LastName><ForeName>Silvana Maria</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tuma</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laselva</LastName><ForeName>Claudia Regina</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neto</LastName><ForeName>Miguel Cendoroglo</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klajner</LastName><ForeName>Sidney</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teich</LastName><ForeName>Vanessa Damazio</ForeName><Initials>VD</Initials><AffiliationInfo><Affiliation>Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kobayashi</LastName><ForeName>Takaaki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edmond</LastName><ForeName>Michael B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>West Virginia University School of Medicine, Morgantown, WV, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marra</LastName><ForeName>Alexandre R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003865" MajorTopicYN="Y">Depressive Disorder, Major</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071066" MajorTopicYN="N">Patient Reported Outcome Measures</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">depression screening</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">mental health</Keyword><Keyword MajorTopicYN="N">middle income countries</Keyword><Keyword MajorTopicYN="N">quality of life</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>6</Day><Hour>3</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38317683</ArticleId><ArticleId IdType="pmc">PMC10839020</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2023.1302669</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . Post COVID-19 condition (long COVID) [internet]. Geneva: WHO; (2023).</Citation></Reference><Reference><Citation>Jin H, Lu L, Fan H. Global trends and research hotspots in long COVID: a bibliometric analysis. Int J Environ Res Public Health. (2022) 19:3742. doi: 10.3390/ijerph19063742, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19063742</ArticleId><ArticleId IdType="pmc">PMC8955790</ArticleId><ArticleId IdType="pubmed">35329428</ArticleId></ArticleIdList></Reference><Reference><Citation>European Centre for Disease Prevention and Control . Prevalence of post COVID-19 condition symptoms: a systematic review and meta-analysis of cohort study data stratified by recruitment setting. Stockholm: ECDC; (2022).</Citation></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. . Characterising long COVID: a living systematic review. BMJ Glob Health. (2021) 6:e005427. doi: 10.1136/bmjgh-2021-005427, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. . The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine. (2022) 55:101762. doi: 10.1016/j.eclinm.2022.101762</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabin R, de Charro F. EQ-5D: a measure of health status from the euro Qol group. Ann Med. (2001) 33:337&#x2013;43. doi: 10.3109/07853890109002087, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/07853890109002087</ArticleId><ArticleId IdType="pubmed">11491192</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB. The patient health Questionnaire-2: validity of a two-item depression screener. Med Care. (2003) 41:1284&#x2013;92. doi: 10.1097/01.MLR.0000093487.78664.3C</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.MLR.0000093487.78664.3C</ArticleId><ArticleId IdType="pubmed">14583691</ArticleId></ArticleIdList></Reference><Reference><Citation>Marra AR, Sampaio VS, Ozahata MC, Lopes R, Brito AF, Bragatte M, et al. . Risk factors for long coronavirus disease 2019 (long COVID) among healthcare personnel, Brazil, 2020&#x2013;2022. Infect Control Hosp Epidemiol. (2023) 5:1&#x2013;7. doi: 10.1017/ice.2023.95 [Epub ahead of print]., PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2023.95</ArticleId><ArticleId IdType="pmc">PMC10755155</ArticleId><ArticleId IdType="pubmed">37272468</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SW. Methods for testing statistical differences between groups in medical research: statistical standard and guideline of life cycle committee. Life Cycle. (2022) 2:e1. doi: 10.54724/lc.2022.e1</Citation><ArticleIdList><ArticleId IdType="doi">10.54724/lc.2022.e1</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodrow M, Carey C, Ziauddeen N, Thomas R, Akrami A, Lutje V, et al. . Systematic review of the prevalence of long COVID, open forum. Infect Dis. (2023) 10:ofad 233. doi: 10.1093/ofid/ofad233, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad233</ArticleId><ArticleId IdType="pmc">PMC10316694</ArticleId><ArticleId IdType="pubmed">37404951</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Notarte KI, Peligro PJ, Velasco JV, Ocampo MJ, Henry BM, et al. . Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants of concern: a systematic review of the literature. Viruses. (2022) 14:2629. doi: 10.3390/v14122629, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122629</ArticleId><ArticleId IdType="pmc">PMC9785120</ArticleId><ArticleId IdType="pubmed">36560633</ArticleId></ArticleIdList></Reference><Reference><Citation>Moy FM, Hairi NN, Lim ERJ, Bulgiba A. Long COVID and its associated factors among COVID survivors in the community from a middle-income country-an online cross-sectional study. PLoS One. (2022) 17:e0273364. doi: 10.1371/journal.pone.0273364, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0273364</ArticleId><ArticleId IdType="pmc">PMC9426885</ArticleId><ArticleId IdType="pubmed">36040960</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair CV, Moni M, Edathadathil F, Prasanna P, Pushpa Raghavan R, Sathyapalan DT, et al. . Incidence and characterization of post-COVID-19 symptoms in hospitalized COVID-19 survivors to recognize Syndemic connotations in India: single-center prospective observational cohort study. JMIR Form Res. (2023) 7:e40028. doi: 10.2196/40028, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/40028</ArticleId><ArticleId IdType="pmc">PMC10131721</ArticleId><ArticleId IdType="pubmed">36920842</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. (2021) 397:220&#x2013;32. doi: 10.1016/S0140-6736(20)32656-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: a systematic review and meta-analysis. EClinicalMedicine. (2021) 36:100899. doi: 10.1016/j.eclinm.2021.100899</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetlevik &#xd8;, Wensaas KA, Baste V, Emberland KE, &#xd6;zg&#xfc;m&#xfc;s T, H&#xe5;berg SE, et al. . Prevalence and predictors of post-COVID-19 symptoms in general practice - a registry-based nationwide study. BMC Infect Dis. (2023) 23:721. doi: 10.1186/s12879-023-08727-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08727-6</ArticleId><ArticleId IdType="pmc">PMC10599052</ArticleId><ArticleId IdType="pubmed">37880583</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P, Patel K, Pinto C, Jaiswal R, Tirupathi R, Pillai S, et al. . Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-a systematic review and meta-analysis. J Med Virol. (2022) 94:253&#x2013;62. doi: 10.1002/jmv.27309, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Rom&#xe1;n-Montes CM, Flores-Soto Y, Guaracha-Basa&#xf1;ez GA, Tamez-Torres KM, Sifuentes-Osornio J, Gonz&#xe1;lez-Lara MF, et al. . Post-COVID-19 syndrome and quality of life impairment in severe COVID-19 Mexican patients. Front Public Health. (2023) 11:1155951. doi: 10.3389/fpubh.2023.1155951, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1155951</ArticleId><ArticleId IdType="pmc">PMC10225709</ArticleId><ArticleId IdType="pubmed">37255755</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuzuki S, Miyazato Y, Terada M, Morioka S, Ohmagari N, Beutels P. Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients. Health Qual Life Outcomes. (2022) 20:125. doi: 10.1186/s12955-022-02033-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-022-02033-6</ArticleId><ArticleId IdType="pmc">PMC9388960</ArticleId><ArticleId IdType="pubmed">35986269</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaspar P, Dias M, Parreira I, Gon&#xe7;alves HD, Parlato F, Maione V, et al. . Predictors of long-COVID-19 and its impact on quality of life: longitudinal analysis at 3, 6 and 9 months after discharge from a Portuguese Centre. Acta Med Port. (2023) 24, 36:647&#x2013;60. doi: 10.20344/amp.19047</Citation><ArticleIdList><ArticleId IdType="doi">10.20344/amp.19047</ArticleId><ArticleId IdType="pubmed">36827994</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. . Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. (2022) 28:1706&#x2013;14. doi: 10.1038/s41591-022-01909-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Bobkova P, Spiridonova E, Shikhaleva A, Gamirova A, Blyuss O, et al. . Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin Exp Allergy. (2021) 51:1107&#x2013;20. doi: 10.1111/cea.13997, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.13997</ArticleId><ArticleId IdType="pmc">PMC8444748</ArticleId><ArticleId IdType="pubmed">34351016</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, et al. . Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-Centre longitudinal study. Clin Microbiol Infect. (2021) 27:89&#x2013;95. doi: 10.1016/j.cmi.2020.09.023, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Quaranta VN, Portacci A, Dragonieri S, Locorotondo C, Buonamico E, Diaferia F, et al. . The predictors of long COVID in southeastern Italy. J Clin Med. (2023) 12:6303. doi: 10.3390/jcm12196303, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12196303</ArticleId><ArticleId IdType="pmc">PMC10573494</ArticleId><ArticleId IdType="pubmed">37834947</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al. . Risk factors associated with post&#x2212;COVID-19 condition: a systematic review and Meta-analysis. JAMA Intern Med. (2023) 183:566&#x2013;80. doi: 10.1001/jamainternmed.2023.0750, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodward SF, Bari S, Vike N, Lalvani S, Stetsiv K, Kim BW, et al. . Anxiety, post&#x2013;COVID-19 syndrome-related depression, and suicidal thoughts and behaviors in COVID-19 survivors: cross-sectional study. JMIR Form Res. (2022) 6:e36656. doi: 10.2196/36656, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/36656</ArticleId><ArticleId IdType="pmc">PMC9604174</ArticleId><ArticleId IdType="pubmed">35763757</ArticleId></ArticleIdList></Reference><Reference><Citation>Fancourt D, Steptoe A, Bu F. Psychological consequences of long COVID: comparing trajectories of depressive and anxiety symptoms before and after contracting SARS-CoV-2 between matched long-and short-COVID groups. Br J Psychiatry. (2023) 222:74&#x2013;81. doi: 10.1192/bjp.2022.155, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.2022.155</ArticleId><ArticleId IdType="pmc">PMC7614126</ArticleId><ArticleId IdType="pubmed">36458509</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62&#x2008;354 COVID-19 cases in the USA. Lancet Psychiatry. (2021) 8:130&#x2013;40. doi: 10.1016/S2215-0366(20)30462-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30462-4</ArticleId><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Re&#x2019;em Y, Stelson EA, Davis HE, McCorkell L, Wei H, Assaf G, et al. . Factors associated with psychiatric outcomes and coping in long COVID. Nat Mental Health. (2023) 1:361&#x2013;72. doi: 10.1038/s44220-023-00064-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s44220-023-00064-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Quan L, Chavarro JE, Slopen N, Kubzansky LD, Koenen KC, et al. . Associations of depression, anxiety, worry, perceived stress, and loneliness prior to infection with risk of post-COVID-19 conditions. JAMA Psychiatry. (2022) 79:1081&#x2013;91. doi: 10.1001/jamapsychiatry.2022.2640, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.2640</ArticleId><ArticleId IdType="pmc">PMC9453634</ArticleId><ArticleId IdType="pubmed">36069885</ArticleId></ArticleIdList></Reference><Reference><Citation>Raony &#xcd;, de Figueiredo CS, Pandolfo P, Giestal-de-Araujo E, Oliveira-Silva Bomfim P, Savino W. Psycho-neuroendocrine-immune interactions in COVID-19: potential impacts on mental health. Front Immunol. (2020) 11:1170. doi: 10.3389/fimmu.2020.01170, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01170</ArticleId><ArticleId IdType="pmc">PMC7267025</ArticleId><ArticleId IdType="pubmed">32574266</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng M, He J, Xue Y, Yang X, Liu S, Gong Z. Role of hypertension on the severity of COVID-19: a review. J Cardiovasc Pharmacol. (2021) 78:e648&#x2013;55. doi: 10.1097/FJC.0000000000001116, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0000000000001116</ArticleId><ArticleId IdType="pmc">PMC8562915</ArticleId><ArticleId IdType="pubmed">34321401</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreutz R, Algharably EAE, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, et al. . Hypertension, the renin&#x2013;angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19. Cardiovasc Res. (2020) 116:1688&#x2013;99. doi: 10.1093/cvr/cvaa097, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa097</ArticleId><ArticleId IdType="pmc">PMC7184480</ArticleId><ArticleId IdType="pubmed">32293003</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kr&#xfc;ger N, Herrler T, Erichsen S, et al. . SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cells. (2020) 181:271&#x2013;280.e8. doi: 10.1016/j.cell.2020.02.052, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Nikravesh M, Chukwuemeka U, Randazzo M, Flores P, Choday P, et al. . Safety of ACEi and ARB in COVID-19 management: a retrospective analysis. Clin Cardiol. (2022) 45:759&#x2013;66. doi: 10.1002/clc.23836, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.23836</ArticleId><ArticleId IdType="pmc">PMC9110920</ArticleId><ArticleId IdType="pubmed">35481554</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Wang X, Chen J, Zhang H, Deng A. Association of Renin-Angiotensin System Inhibitors with Severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan. China JAMA Cardiol. (2020) 5:825&#x2013;30. doi: 10.1001/jamacardio.2020.1624, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1624</ArticleId><ArticleId IdType="pmc">PMC7180726</ArticleId><ArticleId IdType="pubmed">32324209</ArticleId></ArticleIdList></Reference><Reference><Citation>Semenzato L, Botton J, Drouin J, Baricault B, Vabre C, Cuenot F, et al. . Antihypertensive drugs and COVID-19 risk: a cohort study of 2 million hypertensive patients. Hypertension. (2021) 77:833&#x2013;42. doi: 10.1161/HYPERTENSIONAHA.120.16314, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.16314</ArticleId><ArticleId IdType="pmc">PMC7884243</ArticleId><ArticleId IdType="pubmed">33423528</ArticleId></ArticleIdList></Reference><Reference><Citation>Iaccarino G, Grassi G, Borghi C, Ferri C, Salvetti M, Volpe M. SARSRAS investigators age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS study of the Italian society of hypertension. Hypertension. (2020) 76:366&#x2013;72. doi: 10.1161/HYPERTENSIONAHA.120.15324, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.15324</ArticleId><ArticleId IdType="pubmed">32564693</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur B, Dubey P, Benitez J, Torres JP, Reddy S, Shokar N, et al. . A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19. Sci Rep. (2021) 11:8562. doi: 10.1038/s41598-021-88130-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-88130-w</ArticleId><ArticleId IdType="pmc">PMC8058064</ArticleId><ArticleId IdType="pubmed">33879826</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair P, Nair CV, Kulirankal KG, Corley EM, Edathadathil F, Gutjahr G, et al. . Characterization and predictive risk scoring of long COVID in a south indian cohort after breakthrough COVID infection; a prospective single Centre study. BMC Infect Dis. (2023) 23:670. doi: 10.1186/s12879-023-08600-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08600-6</ArticleId><ArticleId IdType="pmc">PMC10563355</ArticleId><ArticleId IdType="pubmed">37814234</ArticleId></ArticleIdList></Reference><Reference><Citation>Comelli A, Viero G, Bettini G, Nobili A, Tettamanti M, Galbussera AA, et al. . Patient-reported symptoms and sequelae 12 months after COVID-19 in hospitalized adults: a multicenter long-term follow-up study. Front Med. (2022) 9:834354. doi: 10.3389/fmed.2022.834354, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.834354</ArticleId><ArticleId IdType="pmc">PMC8981315</ArticleId><ArticleId IdType="pubmed">35391879</ArticleId></ArticleIdList></Reference><Reference><Citation>Reme BA, Gjesvik J, Magnusson K. Predictors of the post-COVID condition following mild SARS-CoV-2 infection. Nat Commun. (2023) 14:5839. doi: 10.1038/s41467-023-41541-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-41541-x</ArticleId><ArticleId IdType="pmc">PMC10511472</ArticleId><ArticleId IdType="pubmed">37730740</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Cancela-Cilleruelo I, Rodr&#xed;guez-Jim&#xe9;nez J, G&#xf3;mez-Mayordomo V, Pellicer-Valero OJ, Mart&#xed;n-Guerrero JD, et al. . Associated-onset symptoms and post-COVID-19 symptoms in hospitalized COVID-19 survivors infected with Wuhan, alpha or Delta SARS-CoV-2 variant. Pathogens. (2022) 11:725. doi: 10.3390/pathogens11070725, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11070725</ArticleId><ArticleId IdType="pmc">PMC9320021</ArticleId><ArticleId IdType="pubmed">35889971</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. (2022) 399:2263&#x2013;4. doi: 10.1016/S0140-6736(22)00941-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>